Communiqués Tactile Systems Technology, Inc.

Actions

TCMD

US87357P1003

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 28/07/2026			Varia. 5j.	Varia. 1 janv.
27,74 ^USD	-0,07%		-2,43%	-4,34%

13/07	Tactile Systems Technology élargit son portefeuille de thérapie par compression grâce à un accord de distribution avec ElastiMed	MT
13/07	Tactile Systems Technology, Inc. conclut un accord de distribution exclusif aux États-Unis avec ElastiMed, Inc. pour le dispositif de compression MyoSleeve destiné aux patients du VA et du DoD	CI

Communiqués

21/07	Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026	AQ
13/07	Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients	AQ
02/06	Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy	AQ
20/05	Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference	AQ
04/05	Tactile Systems Technology: Q1 Earnings Snapshot	AQ
04/05	Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results	AQ
20/04	Tactile Medical to Release First Quarter of Fiscal Year 2026 Financial Results on May 4, 2026	AQ
09/03	Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson	AQ
17/02	Tactile Systems Technology: Q4 Earnings Snapshot	AQ
17/02	Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results	AQ
17/02	Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio	AQ
03/02	Tactile Medical to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026	AQ
18/11	Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference	AQ
03/11	Tactile Systems Technology: Q3 Earnings Snapshot	AQ
03/11	Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results	AQ
28/10/25	Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema	AQ
20/10/25	Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025	AQ
04/08/25	Tactile Systems Technology: Q2 Earnings Snapshot	AQ
04/08/25	Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results	AQ
21/07/25	Tactile Medical to Release Second Quarter of Fiscal Year 2025 Financial Results on August 4, 2025	AQ
03/06/25	New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors	AQ
20/05/25	Tactile Medical to Present at Upcoming Investor Conferences in June	AQ
05/05/25	Tactile Systems Technology: Q1 Earnings Snapshot	AQ
05/05/25	Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results	AQ
21/04/25	Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025	AQ